343
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database

Pages 851-863 | Received 05 Aug 2021, Accepted 07 Oct 2021, Published online: 22 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yosuke Tachibana, Sakura Takasaki, Misuzu Hoshino, Haruki Makioka & Mingshou Jin. (2024) Real-world safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 401 Japanese patients: results from an interim analysis of post-marketing surveillance. International Journal of Neuroscience 134:2, pages 153-162.
Read now
Yosuke Tachibana, Ryusuke Sato, Haruki Makioka, Misuzu Hoshino & Mingshou Jin. (2023) Safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 524 patients: results from an interim analysis of post-marketing surveillance in Japan. International Journal of Neuroscience 0:0, pages 1-13.
Read now
Helgi Thor Hjartarson, Kristofer Nathorst-Böös & Thomas Sejersen. (2022) Disease Modifying Therapies for the Management of Children with Spinal Muscular Atrophy (5q SMA): An Update on the Emerging Evidence. Drug Design, Development and Therapy 16, pages 1865-1883.
Read now

Articles from other publishers (4)

Yuki Ueda, Kiyoshi Egawa, Kentaro Kawamura, Noriki Ochi, Takeru Goto, Shuhei Kimura, Masashi Narugami, Sachiko Nakakubo, Midori Nakajima, Atsushi Manabe & Hideaki Shiraishi. (2024) Nusinersen induces detectable changes in compound motor action potential response in spinal muscular atrophy type 1 patients with severe impairment of motor function. Brain and Development 46:3, pages 149-153.
Crossref
Olga Khorkova, Jack Stahl, Aswathy Joji, Claude-Henry Volmar & Claes Wahlestedt. (2023) Amplifying gene expression with RNA-targeted therapeutics. Nature Reviews Drug Discovery 22:7, pages 539-561.
Crossref
Zhi-Juan Zhong, Pi-Mei Zheng, Hui-Hong Dou & Ji-Gan Wang. (2023) Adverse events in the treatment of spinal muscular atrophy in children and adolescents with nusinersen: A systematic review and meta-analysis. Frontiers in Pediatrics 11.
Crossref
Olga Khorkova, Jack Stahl, Aswathy Joji, Claude-Henry Volmar, Zane Zeier & Claes Wahlestedt. (2022) Natural antisense transcripts as drug targets. Frontiers in Molecular Biosciences 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.